The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors
Rui Zhao(Sichuan University), Yin Yang(Fujian Medical University), Yudong Qiu(Nanjing Drum Tower Hospital), Huanjie Shao(Shaanxi Normal University), Jiawei Shen(Soochow University), Y-H. Chen(Electronics Corporation of India), Shaohua Chen(University of Georgia), Jianjun Liu(University of Kentucky), Tong Liu(Jianghan University), Cheng Huang(Fujian Medical University), Ganggang Shi(Second Hospital of Tianjin Medical University), Yi‐Chin Lin(Fujian Medical University), Yingwen Zhang(Sun Yat-sen University), Tao Tang(Chinese University of Hong Kong), Hung‐Chun Fu(Chang Gung University), Bing Xu(Xi'an University of Architecture and Technology), Shijie Liao(First Affiliated Hospital of GuangXi Medical University)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 0
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Multifunctional biohybrid magnetite microrobots for imaging-guided therapy
|Science Robotics|2017|873
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714